Part, Chapter, Paragraph
1 II, 4. 2 | selected countries.~ ~The conclusion is that the development
2 II, 5. 2. 5| particularly the Council Conclusion from 2004 (Council of the
3 II, 5. 3. 7| the adoption of Council Conclusion on “Reducing the Burden
4 II, 5. 4. 2| 5.4.2.9. Conclusion~ ~Different data sources
5 II, 5. 5. 3| randomized studies, a final conclusion could not be drawn.~Psychotic
6 II, 5. 5. 3| individuals with MS. The important conclusion of this report was that
7 II, 5. 7. 3| Dijk et al, 2001).~ ~In conclusion, as previously emphasised,
8 II, 5. 9. 4| analysis to atopic asthma. In conclusion, atopy and clinical asthma
9 II, 5. 9. 4| specific IgE levels. In conclusion, fine ambient PM fractions
10 II, 5. 11. 6| important clinical questions.~In conclusion, urgent research into the
11 III, 10. 2. 1| especially lipophilic ones.~ ~In conclusion, although Europe like other
12 III, 10. 2. 1| discretionary foods. No unanimous conclusion was reached (EFSA, 2007).~ ~
13 III, 10. 3. 1| and in vitro research. In conclusion, no health effect has been
14 III, 10. 3. 1| 0<f 300 Hz) the previous conclusion from IARC (International
15 III, 10. 3. 1| non-thermal exposure level. In conclusion, no health effect has been
16 III, 10. 4. 2| applicant(s) and public EFSA conclusion; and~· third: risk managers
17 III, 10. 4. 2| in order to reach such a conclusion are discussed in detail
18 III, 10. 4. 5| progressing slowly.~ ~In conclusion, more is being learned on
19 III, 10. 5. 1| certain CDs is higher.~ ~Conclusion~ ~In brief, the indoor dimension
20 III, 10. 5. 2| health status, a more precise conclusion is possible for the provision
21 IV, 13. 3 | healthier European Union. Such a conclusion stems from many different
